FDA Inspection 1018938 — Kettering Health Network (IRB)
The FDA completed an inspection of Kettering Health Network (IRB) on June 29, 2017 in Dayton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 29, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dayton, OH (United States)
Additional Details
IRB